
Medical therapy versus TEVAR for uncomplicated type B aortic dissection
Author(s) -
Varinder Singh Bedi,
Pranati Swain,
Ajay Yadav
Publication year - 2019
Publication title -
indian journal of thoracic and cardiovascular surgery/indian journal of thoracic and cardiovascular surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.114
H-Index - 9
eISSN - 0973-7723
pISSN - 0970-9134
DOI - 10.1007/s12055-019-00837-8
Subject(s) - medicine , cardiothoracic surgery , aortic dissection , aortic repair , vascular surgery , cardiac surgery , surgery , medical therapy , dissection (medical) , aneurysm , aorta
The standard of care in uncomplicated acute type B aortic dissection (uTBAD) has been optimal medical management. Surgical repair and endovascular interventions are adjuncts in managing complicated type B dissection. Increasing safety and confidence in the thoracic endovascular aortic repair (TEVAR) and recent data indicating long-term complications in medical management of uTBAD has brought a shift in treatment approach. TEVAR at best remains controversial, yet there is a subset, which will definitely benefit from intervention.